Health Care
Commentary
Bane of High Health Care Costs Can Be Traced to Obamacare
About 3 in 4 Americans are at least somewhat worried about their ability to afford health care, according to the KFF Health Tracking Poll February 2024. That concern is at odds with their generally favorable view of the Affordable Care Act, which will mark its 14th birthday on March 23. Nearly 6 in ...
Coronavirus
NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Commentary
Read the latest on medicare spending
Competition Or Insolvency? Medicare’s Time For Choosing.
America has a spending problem. Last month, the Congressional Budget Office reported that debt held by the public will exceed the entire economic output of the country next year. Within ten years, the debt will reach 116% of GDP—”an amount greater than at any point in the nation’s history,” as the ...
Commentary
Don’t take away short-term health plans
The Biden administration may soon finalize rules that would deprive many Americans, especially young and healthy ones, of affordable insurance coverage. That will be the consequence of President Joe Biden‘s plan to reverse a 2018 rule promulgated by the Trump administration that allowed low-cost short-term health plans to last up ...
Commentary
Obamacare coverage might be free. But that’s not good.
There’s a saying that nothing good in life is free. The latest Obamacare enrollment numbers are a case in point. The Biden administration recently announced that a record 21.3 million Americans signed up for Obamacare during this year’s open enrollment period. But many of those enrollees only signed up because they ...
Commentary
Read the latest on Senator Sanders' fight against major pharmaceutical firms
Sanders Won’t Let Facts Get In Way of a Good Pharma Shaming
Vermont Senator Bernie Sanders called the CEOs of several major pharmaceutical firms to testify earlier this month before the Senate Health, Education, Labor and Pensions Committee, where he serves as chairman. The hearing’s official purpose was to discuss prescription drug pricing. But it mainly offered Sanders a forum to castigate the pharmaceutical ...
Commentary
Why weakening of intellectual property rules is a threat to California
This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 ...
Commentary
Medical debt isn’t a crisis
The Left has long insisted that medical debt is a national crisis and that the federal government needs to do something about it. They appear to have new ammunition in the form of an analysis published this month by the Peterson Center on Healthcare and KFF. Nearly one in 12 adults — 20.4 million people — had medical debt in 2021, ...
Commentary
Golden State May Learn Single-Payer Mania Has Hefty Price
The California legislature will soon consider yet another bid to launch a government takeover of the state’s health insurance system. Known as the California Guaranteed Health Care for All Act, AB 2200 seeks to ban private health insurance and enroll all state residents — including those currently covered by Medicare and Medi-Cal, ...
Commentary
President Biden Is His Own Worst Enemy In The War On Cancer
Cancer is becoming more common. This year, the number of new cancer cases among Americans is projected to exceed 2 million for the first time ever, according to a paper published last month by the American Cancer Society. The disease is also afflicting people earlier in their lives. Cancer diagnosis rates for ...
Bane of High Health Care Costs Can Be Traced to Obamacare
About 3 in 4 Americans are at least somewhat worried about their ability to afford health care, according to the KFF Health Tracking Poll February 2024. That concern is at odds with their generally favorable view of the Affordable Care Act, which will mark its 14th birthday on March 23. Nearly 6 in ...
NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Read the latest on medicare spending
Competition Or Insolvency? Medicare’s Time For Choosing.
America has a spending problem. Last month, the Congressional Budget Office reported that debt held by the public will exceed the entire economic output of the country next year. Within ten years, the debt will reach 116% of GDP—”an amount greater than at any point in the nation’s history,” as the ...
Don’t take away short-term health plans
The Biden administration may soon finalize rules that would deprive many Americans, especially young and healthy ones, of affordable insurance coverage. That will be the consequence of President Joe Biden‘s plan to reverse a 2018 rule promulgated by the Trump administration that allowed low-cost short-term health plans to last up ...
Obamacare coverage might be free. But that’s not good.
There’s a saying that nothing good in life is free. The latest Obamacare enrollment numbers are a case in point. The Biden administration recently announced that a record 21.3 million Americans signed up for Obamacare during this year’s open enrollment period. But many of those enrollees only signed up because they ...
Read the latest on Senator Sanders' fight against major pharmaceutical firms
Sanders Won’t Let Facts Get In Way of a Good Pharma Shaming
Vermont Senator Bernie Sanders called the CEOs of several major pharmaceutical firms to testify earlier this month before the Senate Health, Education, Labor and Pensions Committee, where he serves as chairman. The hearing’s official purpose was to discuss prescription drug pricing. But it mainly offered Sanders a forum to castigate the pharmaceutical ...
Why weakening of intellectual property rules is a threat to California
This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 ...
Medical debt isn’t a crisis
The Left has long insisted that medical debt is a national crisis and that the federal government needs to do something about it. They appear to have new ammunition in the form of an analysis published this month by the Peterson Center on Healthcare and KFF. Nearly one in 12 adults — 20.4 million people — had medical debt in 2021, ...
Golden State May Learn Single-Payer Mania Has Hefty Price
The California legislature will soon consider yet another bid to launch a government takeover of the state’s health insurance system. Known as the California Guaranteed Health Care for All Act, AB 2200 seeks to ban private health insurance and enroll all state residents — including those currently covered by Medicare and Medi-Cal, ...
President Biden Is His Own Worst Enemy In The War On Cancer
Cancer is becoming more common. This year, the number of new cancer cases among Americans is projected to exceed 2 million for the first time ever, according to a paper published last month by the American Cancer Society. The disease is also afflicting people earlier in their lives. Cancer diagnosis rates for ...
